These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2905394

  • 1. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Aono J, Sakai K.
    Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J, Nabata H, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [Abstract] [Full Text] [Related]

  • 3. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs.
    Imagawa J, Nabata H, Sakai K.
    Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683
    [Abstract] [Full Text] [Related]

  • 4. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K, Baba A, Akima M, Koga T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1989 May; 299():169-84. PubMed ID: 2570554
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH, Sheu JR, Peng IH, Lee YM, Chern JW.
    J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
    [Abstract] [Full Text] [Related]

  • 6. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H, Nagatomo T.
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM.
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [Abstract] [Full Text] [Related]

  • 8. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
    Kawasaki H, Takasaki K.
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
    [Abstract] [Full Text] [Related]

  • 9. Further evaluation of the selectivity of a novel antihypertensive agent, SGB-1534, for peripheral alpha 1-adrenoceptors in the spinally anesthetized dog.
    Imagawa J, Sakai K.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):257-64. PubMed ID: 3028830
    [Abstract] [Full Text] [Related]

  • 10. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W, Nakagawa Y, Mitomi A, Imai S.
    Nihon Yakurigaku Zasshi; 1982 May 19; 79(5):441-9. PubMed ID: 6127291
    [Abstract] [Full Text] [Related]

  • 11. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H, Takasaki K.
    J Pharmacol Exp Ther; 1986 Mar 19; 236(3):810-8. PubMed ID: 3005557
    [Abstract] [Full Text] [Related]

  • 12. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    Shibata S, Satake N, Suh TK, Ishida Y, Ueda S, Follmer C, Flores F.
    Gen Pharmacol; 1986 Mar 19; 17(2):143-9. PubMed ID: 2870954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo experiments for the evaluation of alpha 1-adrenoceptor antagonistic effects of SGB-1534 on canine urethra.
    Imagawa J, Akima M, Sakai K.
    Eur J Pharmacol; 1989 Aug 11; 167(1):167-72. PubMed ID: 2570705
    [Abstract] [Full Text] [Related]

  • 15. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW, Lebel W, Weeks R.
    J Cardiovasc Pharmacol; 1984 Aug 11; 6(1):142-50. PubMed ID: 6199597
    [Abstract] [Full Text] [Related]

  • 16. [Alpha-adrenoceptor blocking action of terazosin].
    Hanazuka M, Horii D, Mizogami S.
    Nihon Yakurigaku Zasshi; 1986 Dec 11; 88(6):433-41. PubMed ID: 2881853
    [Abstract] [Full Text] [Related]

  • 17. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
    Drew GM, Whiting SB.
    Br J Pharmacol; 1979 Oct 11; 67(2):207-15. PubMed ID: 40647
    [Abstract] [Full Text] [Related]

  • 18. Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.
    Lefèvre-Borg F, O'Connor SE, Schoemaker H, Hicks PE, Lechaire J, Gautier E, Pierre F, Pimoule C, Manoury P, Langer SZ.
    Br J Pharmacol; 1993 Aug 11; 109(4):1282-9. PubMed ID: 8104650
    [Abstract] [Full Text] [Related]

  • 19. Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
    Aono J, Sakai K.
    Jpn J Pharmacol; 1986 Dec 11; 42(4):493-500. PubMed ID: 2879951
    [Abstract] [Full Text] [Related]

  • 20. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC, Roach AG, Smith CF.
    Br J Pharmacol; 1983 Mar 11; 78(3):489-505. PubMed ID: 6132640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.